The Global Tobacco and Nicotine Forum (GTNF2023) will be held at the Conrad Hotel in Seoul, South Korea from September 19th to 21st, 2023. Experts, government representatives, and industry leaders from around the world will gather to discuss the future development and innovation of the tobacco and nicotine industry. 2FIRSTS will report on the key themes and speeches of this forum.
Since its debut in 2008, GTNF has been a renowned forum in the tobacco and nicotine industry, aiming to foster inter-disciplinary dialogue, drive innovation, and shape the future together. On this distinctive platform, public health experts, government representatives, tobacco industry leaders, and investors come together to share perspectives and ideas, and discuss industry trends and challenges.
The theme of this year's GTNF is "Change the Conversation. Change the Outcome." Representatives attending the event will explore how to shape a more positive future by altering the way dialogue takes place. Renowned companies such as Philip Morris International (PMI), British American Tobacco (BAT), Japan Tobacco International (JTI), Imperial Brands (IB), Smoore (SMOORE), JUUL, as well as experts in the tobacco field and representatives from regulatory agencies such as the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration, tobacco experts from Yunnan University, and the Director of the Saw Swee Hock School of Public Health at the National University of Singapore, will share their perspectives and research findings.
GTNF2023 will be a unique platform for all stakeholders in the industry to discuss the current challenges and opportunities. Participants will have the opportunity to learn about the latest research findings, policy trends, and innovative technologies, and collectively drive the future development of the tobacco and nicotine industry. This year's forum will focus on several topics, including sustainable development, research and innovation of next-generation tobacco products, and harm reduction economics.
2FIRSTS will be present at GTNF2023, providing coverage of the forum's key highlights and engaging in in-depth conversations with industry professionals, offering the latest insights and perspectives on the global tobacco and nicotine sector. Stay tuned for 2FIRSTS' coverage to stay updated on the latest developments at GTNF2023.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
